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Variant selection and blood-borne "clonogenic" tumour cells
in metastasis of FSA cell clones
N. Suzuki
Johns Hopkins Oncology Center, 600 North Wolfe Street, Baltimore, Maryland 21205, U.S.A.
Summary Our studies of the metastatic behaviour of FSA1231 and FSA1233 show that the role of selection
processes of metastatic variants at the secondary sites is minimal in the spontaneous metastasis of these
systems. In contrast, tumour-cell release efficiency (number of blood-borne clonogenic tumour-cells) correlates
well with the difference in spontaneous lung metastasis efficiencies of the cell clones FSA1231 and FSA1233.
Also, the different tumour-cell release efficiencies could explain the discrepancy between artificial and
spontaneous metastasis of these cell clones.
Metastasis involves multiple complex steps, from
tumour-cell release into the systemic circulation to
deposition and new growth at the secondary sites.
Numerous studies of over 20 years on patients'
blood failed to establish a positive correlation
between the presence of tumour cells in the blood
and prognosis (Goldblatt & Nadel, 1965; Salsbury,
1975). This negative conclusion on the role of
blood-borne tumour cells along with a view of
organ specific distribution of metastasis, which is
attractive and had been a subject of controversy for
many years, might have led investigators' attention
to the selection processes at the secondary sites.
Heterogeneity of metastatic potential among
tumour cells and selection processes of metastatic
variants at the secondary sites have been the major
focus of metastasis studies in the past 10 years from
many laboratories (Fidler, 1973; Nicolson &
Winkelhake, 1975, Fidler & Kripke, 1977; Brunson
et al., 1978; Dexter et al., 1978; Neri et al., 1982;
Nicolson & Custead, 1982; Raz et al., 1981;
Talmadge & Fidler, 1982; reviews; Fidler et al.,
1978; Poste & Fidler, 1980, Fidler & Hart, 1982)
including our own (Suzuki & Withers, 1977, 1978,
1979; Suzuki et al., 1978). One of the hypotheses
advocated by many of these studies is that
metastatic foci may be formed by cells from a
primary tumour which are unique in their
capability to metastasize, i.e., metastatic cells evolve
from the primary tumour cell population as a result
of the production of variants during neoplastic
development (Foulds, 1969), and then selection of
suitable ones for metastasis occurs through
metastatic processes.
In these studies, heterogeneity of metastatic
potential among tumour cells is well established.
However, the role of selection processes in
spontaneous metastasis remains to be determined.
Recent studies on our FSA cell clone system
(clones isolated from a methylcholanthrene-induced
mouse fibrosarcoma) showed that FSA1231 cells are
more efficient in spontaneous lung metastasis than
FSA1233 cells, while FSA1233 cells are more
efficient in artificial lung metastasis through i.v.
injection than FSA1231 cells (Suzuki et al., 1980).
Therefore, the FSA1231-1233 cell system
discriminates artificial and spontaneous lung
metastatic processes. More evidence supporting the
idea that spontaneous and artificial metastasis are
not necessarily the same has come from other
laboratories also using different tumour systems
(Mantovani et al., 1981; Stackpole, 1981; Sweeney et
al., 1982). We have also added further data
indicating a difference between the two methods,
i.e., involvement of host/primary-tumour
interactions and/or tumour-cell release affecting
spontaneous metastasis (effect of whole body
irradiation) (Suzuki, 1983a).
Thus, selection processes (e.g., through organ
specific affinity, Nicolson & Winkelhake, 1975) at
the secondary sites for metastatic variants do not
explain the clonal difference of the present system,
i.e., if the selection at the secondary sites is the main
determinant of metastasis, a clone superior to
another should be so in either artificial or
spontaneous metastasis. Selection processes at the
secondary sites may not be critical determinants in
spontaneous metastasis of the present system.
Previous studies with this system showed that lung
nodules increase faster in size in FSA1231 tumour-
bearing mice than in those with FSA1233 tumours.
Tumour-cell release (TCR) processes and host
changes during primary tumour growth, which are
not involved in artificial metastasis, may be more
important. Such a hypothesis seems to offer a better
explanation of the metastatic behaviour of the
FSA1231 and FSA1233 clones.
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In the present investigation, we first examined
whether cells cultured from metastatic nodules in
the lung (spontaneously arising after production of
a primary tumour by i.m. inoculation of tumour
cells in a leg) had enhanced spontaneous metastatic
ability compared with the original tumour cells.
Secondly, we examined the efficiency of tumour-cell
release (TCR) by quantitating blood-borne
clonogenic tumour-cells with a clonogenicity assay
in vitro of lung-trapped tumour cells during 22h
after 150Gy of thorax irradiation (lung-mediated
CTCR rate assay) (Suzuki, 1983b).
Materials and methods
Tumour cells
FSA cell clones were isolated by soft agar cloning in
vitro (Suzuki & Withers, 1978) from a syngeneic
fibrosarcoma to C3H/HeJ mice. The cell clones
have been characterized regarding their malignant
and related properties (Suzuki & Withers, 1977;
1979; Suzuki et al., 1977, 1978, 1980). The FSA cell
clones have been cryopreserved; cultures were
replaced with freshly thawed cells every month.
Hsu's modified McCoy's 5A medium supplemented
with 15% foetal bovine serum (GIBCO, Grand
Island, New York, N.Y.) was used.
Spontaneous lung metastasis efficiency (SLME)
determination
For determination of SLME, 106 cells were
inoculated i.m. into the hind leg of each syngeneic
C3H/HeJ mouse (male, 9-11 weeks old; purchased
from The Jackson Laboratories, Bar Harbor,
Maine). Mice were killed after 45 days, the lungs
were placed in Bouin's fluid, and surface nodules
were macroscopically counted (Suzuki et al., 1978).
In these conditions, primary tumours develop in
100% of inoculation sites. For indirect estimate of
timing and efficiency of TCR (metastatic spread),
amputation was performed at specified times after
the tumour cell inoculation under pentobarbital
sodium anesthesia (40mgkg-1) with cauterization
of major blood vessels, and the mice were killed 20
days later.
Testfor variant selection
The cells from secondary nodules, which were
developed by the standard SLME determination
method or i.v. injection method, were propagated in
culture about 10 days prior to injection for SLME
measurement.
Lung-mediated assay ofblood-borne clonogenic tumor
cells (CTCR rate assay)
The method has been described in detail elsewhere
(Suzuki, 1983b). Mice were inoculated i.m. in a hind
leg with 106 FSA1231 or FSA1233 cells suspended
in 0.1 ml medium. The cell suspensions were
prepared from late log phase in vitro cultures. The
mice were irradiated with 150Gy locally at the
thorax 32-40 days later using a 137Cs y-ray
irradiator at 11.5Gy min- under anesthesia with
pentobarbital sodium (40mgkg-1). The thorax
irradiation was intended to eradicate tumour cells
already metastasized to the lung as well as normal
cells in the lung, and also possibly to enhance lung
trapping and retention of tumour cells (Fidler &
Zeidman, 1972; Brown, 1973; Van den Brenk, 1973;
Withers & Milas, 1973; Peters et al., 1978, 1980;
Grdina et al., 1978). The mice (3 mice per group)
were killed immediately (Oh-control) or 22h after
irradiation. Appropriateness of thorax irradiation
setting is obvious from the fact that there were no
tumour cell colonies in Oh control flasks (Figure 1).
Thus, colonies formed in 22h groups are those of
newly released and lung-trapped tumour cells
during the 22h. The lungs were removed and rinsed
with cold physiological saline, minced with scissors,
incubated for 1 h at 37°C with 1 mgml- neutral
protease (Type IX, Sigma Chemical Co., St. Louis,
Mo.) and 1 mgml-1 DNase I (DN-25, Sigma
Chemical Co.) in Puck's saline G and then stirred
for 30min at room temperature. The whole
preparation was washed 3 times by centrifugation.
The cell suspensions were placed with 5 x 104ml-
of 120Gy irradiated feeder cells (FSA1231 or
FSA1233 cells) in 150cm2 flasks (Corning Glass
Works, Coming, New York) containing 20ml
McCoy's 5A medium supplemented with 15%
foetal bovine serum (GIBCO, Grand Island, N.Y.)
(Figure 1 experiments). Later, in the experiments of
Table II, the lung suspensions were plated in 10cm
dishes instead of flasks (one mouse/lOml
medium/dish) without addition of feeder cells. Two
days later, 10ml medium was added and thereafter
medium was changed every 4 days with careful
handling to avoid disrupting colonies. Colonies
were stained 2 weeks later with 0.5% crystal violet
solution in 95% ethanol. Malignant tumour cells,
filtered from blood during the 22h incubation time
after the 150Gy thorax irradiation, formed
colonies. The tumour cell colonies were large and
thick compared to the background normal cells
(thin colony-like growth but not reproductive one),
which did not disturb counting of tumour cell
colonies. The tumour cell colonies were identifiable
by specific DNA content (Figure 2) of each cell
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Cell counting and volume analysis
Cell counts and volume distribution analysis were
carried out with a Model ZBI Coulter counter and
a Channelyzer II multichannel analyzer and plotter
(Coulter Electronics, Hialeah, Florida). The system
was calibrated with latex beads. The average cell
volume for cells in a given sample was calculated
from the modal channel number of the volume
distribution (Suzuki et al., 1977, 1980). As a routine
procedure, the cells from culture were always
monitored for cell number and modal peak position
of the cell volume distribution. This and flow
cytometric (FCM) analysis of the cell suspensions
assured reproducibility of the experiments.
Flow cytometry (FCM)
Cells were first fixed with 70% ethanol and stained
with mithramycin (Mithracin; Charles Pfizer and
Co., Inc., New York, N.Y.) for DNA content
analysis according to the method described by
Crissman and Tobey (Crissman & Tobey, 1974), as
used earlier (Suzuki et al., 1977; Suzuki & Withers.
1977; Suzuki et al., 1980). The staining solution
contained mithramycin, 50 jgml -
, and 7.5mM
MgCl2 in 12.5% aqueous ethanol. FCM analysis
was performed using a FACS II (Becton Dickinson,
Sunnyvale, California) with laser wavelength setting
of 457.9 nm.
Results
In Table I, the spontaneous metastasis efficiencies
(SLME) of the original FSA1231, FSA1233 cells
and cells derived from their secondary lung nodules
through spontaneous metastasis from leg tumours
or through artificial metastasis by i.v. injection, are
presented. SLC designates cells derived from a
spontaneously metastasized lung nodule, and SLM
are those established by pooling spontaneously-
metastasized lung nodules. The SLME of these cells
cultured from the secondary nodules, either single
(SLC) or pooled (SLM), was not higher than that of
the parental cells (FSA1231 and FSA1233) with one
exception (SLC4) out of 14 separate experiments.
These results show that the SLME of the cells
derived from secondary nodules was not enhanced
after a single passage of spontaneous metastasis
processes in the present system. On the other hand,
as shown in previous studies (Suzuki & Withers,
1979), selection processes in the lung were clearly
demonstrated for artificial lung metastasis after i.v.
injection. Thus, in the FSA cell clone system,
selection processes for cells with higher lung
colonizing potential clearly exist for "artificial"
metastasis, but such selection processes cannot be
Table I Selection processes in spontaneous lung
metastasis
Metastasis Lung
Cells Incidence (%) Nodules/Mouse Range
FSA1231
Original 25/70 36 0.89+0.22 0-9
SLC1 5/16 38 0.44+0.18 0-2
SLC2 8/22 36 0.89+0.29 0-4
SLC3 2/15 13 0.20+0.14 0-2
SLM1 2/17 12 0.15+0.10 0-2
SLM2 2/13 17 0.15+0.10 0-1
SLM3 7/20 35 0.75+0.29 0-5
FSA1233
Original 10/98 10 0.21 +0.09 0-8
SLC1 2/18 11 0.14+0.07 0-3
SLC2 2/15 13 0.13+0.09 0-1
SLC3 1/17 6 .0.06+0.06 0-1
SLC4 17/20 55 0.85+0.23* 0-4
SLM1 1/13 8 0.23+0.23 0-3
SLM2 1/20 5 0.05+0.05 0-1
ALMI 1/12 8 0.08+0.08 0-1
ALM2 7/32 22 0.28+0.10 0-2
Lung Nodules/Mouse: Total lung nodule number
divided by total mouse number (mean+s.e.).
SLC: Cells cultured from a single lung colony of
spontaneous metastasis from an i.m. inoculated tumour.
SLM: Cells cultured from a mixture of pooled lung
colonies of spontaneous metastasis from an i.m.
inoculated tumour.
ALM: Cells cultured from a mixture of lung colonies of
artificial metastasis by tail vein injection.
*Significant elevation by t-test (P=0.006).
demonstrated in spontaneous metastasis from leg
tumours.
In previous studies (Suzuki et al., 1980), more
efficient dissemination of FSA1231 compared with
FSA1233 was observed by measuring SLME at
different times after i.m. inoculation of these tumour
cells in the leg. In the present study, we attempted
to obtain additional data on timing and efficiency
of metastatic spread (tumour-cell release) by
amputation of tumour-bearing legs at various times
after i.m. inoculation of tumour cells. However, as a
result of the necessity of amputating tumour-
bearing legs in the early stage to avoid difficulties in
resection of large tumours, very limited numbers of
metastases were obtained (data are not shown). In
theory, these experiments with serial amputations of
tumour bearing legs should allow an indirect
estimate of the efficiency or rate of tumour-cell
release (TCR), but growth processes at the
secondary sites other than TCR are involved and
this can affect the results. To specifically determine
the role of TCR, we applied a newly developed
lung-mediated CTCR rate assay for measurement ofN. SUZUKI
Figure 1 Colonies developed from lung-trapped
blood-borne tumour cells. Top: FSA1231 (left, feeder
cells alone; middle, Oh control; right, 22h). Bottom:
FSA1233 (left, feeder cells alone; middle, Oh control;
right, 22h). Large dense spots are tumour-cell
colonies. No tumour-cell colonies in Oh control and
feeder cells alone.
blood-borne clonogenic tumour cells (Suzuki,
1983b).
Figure 1 shows colonies in 150cm2 flasks.
Normal cells in the background were very limited
(the thorax was preirradiated with 150Gy; Oh
control flasks have these background normal cells
only) and did not disturb quantitation of tumour
cell colonies, which were considerably larger and
more dense. Microscopically, there was an obvious
difference between the tumour cell colonies and
colony-like normal cell growth; tumour cells were
randomly overlapping while normal cells were in
one layer of diffuse growth. These colonies were
identified as tumour cells (Figure 2) by specific G1
DNA content of each cell clone, i.e., 1.6 (FSA1231)
and 3.1 (FSA1233) fold greater than G1 normal
cells (Suzuki & Withers, 1977), and tumorigenicity
in the syngeneic host mice (with i.m. inoculation of
2 x 106 cells) using trypsinized cell suspensions from
the flasks. Comparison of colony number and
SLME for FSA1231 and FSA1233 indicates a
positive correlation between the number of
clonogenic tumour cells in the blood and SLME
(Table II). FSA1231 tumours, although smaller in
size, developed more lung nodules than FSA1233
tumours at all different observation times (32-61
a
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Figure 2 DNA content profile of the cells from the
colonies. Cellular DNA content profiles were
determined by FCM of the trypsinized cell suspensions
from the flasks (a, FSA1231; b, FSA1233). Normal
cell peaks are at around channel 20.
days for tumour size and 45-61 days for SLME
after i.m. inoculation, Table II of the present study
and Table III of Suzuki et al., 1980). One may
assume 13-19 days for trapped tumour cells to
form visible lung nodules; however, this kind of
assumption may not be meaningful in spontaneous
metastasis, where tumour-cell release is likely to be
continuous and may promote the growth of
preseeded tumour cells. CTCR rate did not change
between 32 and 40 days post i.m. inoculation and
probably had reached a plateau by at 32 days in
both tumours. Plating efficiency of FSA1231 cells
was the same as that of FSA1233 as described
elsewhere (Suzuki & Withers, 1978); therefore, the
higher colony number of FSA1231 over FSA1233
in Figure 1 and Table II was not due to differences
in plating efficiency. Actual recovery percentages of
these tumour cells through the assay procedures
could be estimated experimentally by i.v. injection
(through a tail vein) of known numbers of
FSA1231 or FSA1233 cells prepared from cultures
(although cultured cells are not exactly the same as
spontaneously released tumour cells) followed by
preparation of lung cell suspensions and colony
formation in vitro at Oh and 22h later as routinely
done for CTCR assay (Table II). Thus, FSA1231
and FSA1233 tumours apparently shed 1,220 and
460 clonogenic tumour cells respectively into the
blood during the 22h "collection" period if the
recovery data with i.v. injection of cultured cells are
used. These corrected figures for CTCR indicate
essentially the same conclusion as the raw data, i.e.,VARIANT SELECTION AND BLOOD-BORNE "CLONOGENIC" TUMOUR CELLS 831
Table II Clonogenic tumor cell release and SLME
FSA1231 FSA1233 (P)
32+2
days tumours
Tumour
volume 3,000+100 (43) 3,900+300 (27) <0.003
CTCR rate 19.8+2.6 (9) 8.4+2.0 (5) <0.012
40+2
days tumours
Tumour
volume 6,000+300 (29) 8,700+500 (24) <0.001
CTCR rate 17.8 +1.5 (7) 10.1+1.5 (6) <0.005
Combined
CTCR rate 18.9+1.6 (16) 9.3+ 1.2 (11) <0.0002
Recovery
Oh 1.87+0.13 (15) 1.72+0.17 (19)
22h 1.22+0.06 (15) 2.30+0.30 (19)
Mean 1.55 2.01
Corrected
CTCR rate 1,220 460
SLME 0.89+0.22 (70) 0.21 +0.09 (98)
Tumour volume: (X/6) (a x b x c) in mm3, three diameters
were measured by a caliper. Mean+s.e. of number of mice
shown in parentheses.
CTCR rate assay: Lung-mediated, tumour-cell release
rate assay expressed as colonies/22h/mouse (mean+ s.e. of
means of separate experiments). The figures in parentheses
indicate the number of separate experiments. Each
experimental group in separate experiments included 3
mice. Colonies are derived from tumour-cells released into
the blood and trapped in the lung during 22h (no tumour
cell colonies were formed in Oh control).
Recovery: Colony numbers/i.v. injected tumor-cells
prepared from culture expressed in percentage (mean+ s.e.
of petri dishes shown in parentheses). Thorax irradiated
normal mice were injected through a tail vein with
5 x 104/mouse tumour cells suspended in 0.25ml medium.
They were killed immediately (Oh) or 22h later and lung
cell suspensions were prepared in the same manner as
CTCR assay.
Corrected CTCR rate: (combined CTCR rate/mean of %
recovery at 0 and 22h) x 100.
SLME: Spontaneous lung metastasis efficiency. Mean
+s.e. of lung nodules/mouse for shown number of mice in
parentheses (from Table I).
Statistical significance comparing FSA1231 with
FSA1233: P-values were calculated by t-test.
a higher tumour-cell release rate for FSA1231 than
for FSA1233.
Discussion
In spontaneously occurring metastasis there is
probably no repeated selection. Metastatic variants
isolated by repeated cyclic passages in vitro and in
vivo may have their organ specific affinity
genetically concentrated (Zeidman, 1981) and
exaggerate the role of organ specific selection
processes in spontaneous metastasis. Therefore, we
isolated spontaneous lung nodules after only one
selection step and compared their spontaneous
metastasis frequency with parental tumour cells.
Interpretation of our negative results is somewhat
unclear; it may mean either (1) selection processes
may not be important in our system, (2) variants
may be very unstable and may have lost the
"selected" property during growth at the secondary
sites or during the test procedures, or (3) the
variation may not be genetic (e.g., adaptation
proposed by Weiss, 1979). However, the relatively
low frequency of lung nodule formation does not
favour epigenetic changes (third possibility) such as
enzyme induction. The second possibility of false
negativity by instability of secondary nodule cells is
unlikely in the present system, since the same
procedure (a single process of lung colonization,
culture and test of the secondary nodule cells
derived from artificial lung metastases after tail vein
injection) showed a clearly demonstrable
enhancement of lung colony forming efficiency
(Suzuki & Withers, 1979). Thus, we interpret our
results as indicating that selection processes for
variants with enhanced metastatic potential are
demonstrable and important only in artificial
metastasis and not in spontaneous metastasis of the
FSA cell clones. The discrepancy between the two
methods, i.e., that selection of variants was
demonstrable in artificial lung metastasis by i.v.
injection but not in spontaneous lung metastasis
from i.m. injected leg tumours, may reflect the
complex and multifactorial nature of spontaneous
metastasis, which includes host/primary tumour
interaction and TCR processes. For example,
clonogenic tumour cells which happen to be
protected by other neighboring tumour cells (shed
before or later) may survive to form nodules under
continued shedding of tumour cells. Thus, selection
at the secondary sites may not work and the
survival may be a random phenomenon.
Observation of the lack or minimal role of
selection processes for enhanced metastatic
potential in spontaneous metastasis may not be
limited only to the present system (Giavazzi et al.,
1980; Weiss, 1983). Thus, the metastatic variant
hypothesis, which is supported mainly by the results
obtained using artificial metastasis methods,
obviously needs more careful examination using
various spontaneous metastases systems.
We hypothesize that one possible determinant for
spontaneous metastasis could be the TCR process.
For example, the superiority of FSA1231 over
FSA1233 in spontaneous metastasis, unlike artificial832 N. SUZUKI
metastasis, may originate from a difference in the
efficiency of TCR or entry into the circulation.
Another possible important factor may be changes
in the host during primary-tumour growth which
may affect metastasis; artificial metastasis using
healthy mice does not involve host/primary-tumour
interactions. How such host/primary-tumour
interactions affect clonal differences of metastasis
has not been adequately studied.
The possibility of promoting metastasis during
diagnostic and therapeutic procedures by inducing
TCR from the primary has been suspected (Kaplan
& Murphy, 1949; Sheldon & Fowler, 1973; Peters
1975; Baker et al., 1981), though numerous studies
of over 20 years on patients' blood failed to
establish a positive correlation between the presence
of tumour cells in the blood and prognosis
(Goldblatt & Nadel, 1965; Salsbury, 1975).
Interpretation of data regarding tumour cells in
patients' blood is very difficult since most studies
used cytological microscopic identification of fixed
cells isolated from very small amounts of blood (5-
10ml) (Salsbury, 1975) relative to the total human
blood volume. Furthermore, in most studies, the
source of the blood samples was irrelevant to
tumour sites, and clonogenicity and tumorigenicity
ofthese cells were not evaluated.
Thus, new methods for determining blood-borne
"clonogenic" tumour cells are necessary to define
which is (are) the most important process(es) in
spontaneous metastasis. In the present study, a
newly developed lung-mediated CTCR assay
(Suzuki, 1983b) was used to specifically evaluate the
role of TCR. This method allowed us to determine
"clonogenic" tumour cells and their tumorigenicity,
which microscopic identification of tumour cells
after filtration of a small amount of blood does not
permit. These are major advantages, since previous
studies were limited by small amounts of available
blood, and somewhat uncertain techniques for
identification of blood-borne tumour cells
(Salsbury, 1975). During the 22h incubation time
after pre-irradiation, about 1,300ml of blood would
be filtered by the lung if 1 mlmin-1 for blood flow
is assumed (Liotta et al., 1974). Thus, the method
allows us to determine the release rate of
"clonogenic" tumour cells from the primary
tumour and the method is applicable to a system
with less frequent tumour cells released in the
blood. This method does not require complex
operations such as insertion of cannulae into the
tumour blood vessels and perfusion of tumours,
and similarly avoids potential perturbations of the
animal and tumour by such techniques.
While the conventional conclusion elucidated
from the numerous clinical studies has been that
mere existence of tumour cells in the blood
circulation is not indicative of poor prognosis or
inevitable metastasis development (Salsbury, 1975),
the present results indicate that number of
"clonogenic" tumour-cells released from the
primary into the blood or clonogenic tumour-cell
release rate may explain both the difference of
SLME between FSA1231 and FSA1233 and the
discrepancy in artificial and spontaneous metastasis
efficiency of these two cell clones.
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